| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 31-Dec-08 | | Total Revenue | 41,178 | 40,968 | 42,287 | 51,822 | | Cost of Revenue | 12,038 | 14,976 | 13,464 | 14,939 | | | Gross Profit | 29,140 | 25,992 | 28,823 | 36,883 | | | Operating Expenses | | Research Development | 6,756 | 7,704 | 8,835 | 8,970 | | Selling General and Administrative | 21,281 | 22,404 | 26,141 | 29,267 | | Non Recurring | 223 | 3,738 | 297 | 258 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 880 | (7,854) | (6,450) | (1,612) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 262 | 25 | 2,292 | 3,518 | | Earnings Before Interest And Taxes | 1,142 | (7,829) | (4,158) | 1,906 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,142 | (7,829) | (4,158) | 1,906 | | Income Tax Expense | (3,359) | (1,410) | (748) | 92 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,501 | (6,419) | (3,410) | 1,814 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,501 | (6,419) | (3,410) | 1,814 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,501 | ($6,419) | ($3,410) | $1,814 |
|
1.52% Nasdaq 0.00%
Income Statement
